phrykt

West Pharmaceutical Services Inc (WST): who owns it and who trades it

As of Nov 16, 2026, WST insiders reported 8 open-market sales worth $6.6M and no purchases in the last 12 months, with 41% of the sale value made under pre-set 10b5-1 plans. The largest seller was Annette F Favorite (Vice president), with $6.3M. 10 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling West Pharmaceutical Services

From the latest filings

Overall: more selling than buying. Insiders mostly sold. Famous investors was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Insider trades

In the last 12 months, WST insiders reported $0 of open-market purchases and $6.6M of sales. 41% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$6.6M
8 trades, 2 people
Sales under a 10b5-1 plan
41%
Share of sale value
Latest trade
Sep 15, 2026
Filed Sep 15, 2026

Purchases and sales by month

$5.4M$5.4MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Sep 15, 2026Annette F FavoriteVice presidentSale plan2,524$365.00$921KForm 4
Sep 14, 2026Annette F FavoriteVice presidentSale plan2,500$355.00$888KForm 4
Sep 11, 2026Annette F FavoriteVice presidentSale plan2,500$345.00$862KForm 4
Sep 8, 2026Annette F FavoriteVice presidentSale2,818$340.81$960KForm 4
Sep 8, 2026Annette F FavoriteVice presidentSale2,500$340.81$852KForm 4
Sep 8, 2026Annette F FavoriteVice presidentSale2,817$340.81$960KForm 4
Apr 27, 2026Annette F FavoriteVice presidentSale2,817$305.20$860KForm 4
Apr 27, 2026Chad WintersVice presidentSale896$300.67$269KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Annette F FavoriteSr. VP & Chief HR Officer–$6.3MSep 15, 2026
Chad WintersVP, Chief Accounting Officer–$269KApr 27, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

WST short interest

Low short interest. 2.6% of WST shares are sold short: about 1 share in 39. Over the last 12 reports the number of shares short went down 21%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 1.81M WST shares were sold short, 2.6% of the shares outstanding, down 10.2% from the report before. At the average daily volume of 774,083 shares, buying them all back would take about 2.3 trading days (days to cover).

Shares short, % of all shares

2.59%May 15Oct 303.71%

Days to cover

2.3May 15Oct 305.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20261.81M2.59%-10%774,0832.3
Oct 15, 20262.01M2.86%-4%482,5414.2
Sep 30, 20262.10M2.99%-12%674,5393.1
Sep 15, 20262.38M3.38%+8%526,9364.5
Aug 31, 20262.20M3.12%+3%449,3994.9
Aug 14, 20262.12M3.02%-15%516,2614.1
Jul 31, 20262.51M3.57%+6%987,2272.5
Jul 15, 20262.36M3.34%+2%659,6893.6
Jun 30, 20262.32M3.28%+1%994,3582.3
Jun 15, 20262.29M3.24%-2%650,3433.5
May 29, 20262.33M3.29%+2%690,6743.4
May 15, 20262.28M3.23%-6%869,4172.6

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded WST

Since Nov 17, 2024, 3 members of Congress reported 2 purchases and 3 sales of WST. The latest was a sale by Lisa C. McClain on Jul 22, 2025, reported Aug 13, 2025.

Purchases 2Sales 3

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Jul 22, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseAug 13, 2025Report
Jun 17, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseAug 13, 2025Report
Apr 8, 2025Robert P. Bresnahan, Jr. (R-PA)Sale$1K–$15KSelfMay 8, 2025Report
Feb 25, 2025Robert P. Bresnahan, Jr. (R-PA)Purchase$1K–$15KSelfMar 27, 2025Report
Feb 13, 2025Jared Moskowitz (D-FL)Sale$1K–$15KChildMar 6, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

West Pharmaceutical Services company events

West Pharmaceutical Services filed 11 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership, cyberattack). The latest was on Oct 29, 2026.

  1. Oct 29, 2026ResultsReleased financial results. Filing
  2. Oct 26, 2026AgreementThe information contained in Item 2.03 below is incorporated herein by reference. Filing
  3. Jul 23, 2026ResultsReleased financial results. Filing
  4. Jul 14, 2026AgreementWest Pharmaceutical Services, Inc. and Daikyo Seiko, Ltd. have entered into an Amended and Restated Technology Exchange and Crosslicense Agreement as well as two Distributorship Agreements effective July 14, 2026. Filing
  5. Jun 1, 2026LeadershipWest Pharmaceutical Services, Inc. filed a Current Report on Form 8-K announcing that Mr. Eric M. Green, President, Chief Executive Officer and Chair of the Board of Directors of the Company, informed the Board on March 6, 2026 of his intent to retire from those positions once his successor has… Filing
  6. May 20, 2026CyberattackAmended an earlier report. As previously disclosed in the Original Report, the Company determined on May 7, 2026 that the Company had experienced a material cybersecurity attack, in which certain data was exfiltrated by an unauthorized party and certain systems were encrypted. Filing
  7. May 11, 2026CyberattackWest Pharmaceutical Services, Inc. determined that the Company has experienced a material cybersecurity attack, in which certain data was exfiltrated by an unauthorized party and certain systems were encrypted. Filing
  8. May 5, 2026VoteReported shareholder vote results. Filing
  9. Apr 23, 2026ResultsReleased financial results. Filing
  10. Mar 9, 2026LeadershipToday, March 9, 2026, West Pharmaceutical Services, Inc. announced that Mr. Eric M. Green, President, Chief Executive Officer and Chair of the Board of Directors (the “Board) of the Company, informed the Board on March 6, 2026 of his intent to retire from those positions once his successor has been… Filing
  11. Feb 12, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

West Pharmaceutical Services financials

Famous investors that hold WST

10 of the 50 well-known investors we track reported holding WST in their latest 13F filing. The largest position is Bill Gates's, worth $165M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Bill Gates · Gates Foundation TrustQ3 2026444,500$165M0.6%No change
Steve Cohen · Point72 Asset ManagementQ3 2026320,705$119M0.2%+13%
Israel Englander · Millennium ManagementQ3 202658,021$21.5M0.0%+173%
Jim Simons · Renaissance TechnologiesQ3 202646,560$17.3M0.0%+51%
Ray Dalio · Bridgewater AssociatesQ3 202637,099$13.8M0.1%+256%
Ken Griffin · Citadel AdvisorsQ3 202623,098$8.6M0.0%-93%
Jeremy Grantham · GMOQ3 20265,411$2M0.0%-4%
Paul Tudor Jones · Tudor Investment CorpQ3 20264,814$1.8M0.0%-80%
Lee Ainslie · Maverick CapitalQ3 2026722$268K0.0%New
Ken Fisher · Fisher Asset ManagementQ3 2026614$228K0.0%-7%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named WST in the last 120 days.

FiledHolderFormStake
Nov 5, 2026FMR LLC13G/A8.5%
Nov 5, 2026FMR LLC13G/A8.5%

Questions about West Pharmaceutical Services Inc (WST) stock

Are WST insiders buying or selling?

In the last 12 months, WST insiders reported no open-market purchases and 8 sales worth $6.6M. The latest trade was on Sep 15, 2026. See every trade.

What is the short interest in WST?

As of Oct 30, 2026, 1.81M WST shares were sold short, 2.6% of the shares outstanding, down 10.2% from the report before. At the average daily volume of 774,083 shares, buying them all back would take about 2.3 trading days (days to cover). See the history.

Have members of Congress traded WST?

Yes. 3 members of Congress reported 2 purchases and 3 sales of WST since Nov 17, 2024. The latest was reported on Aug 13, 2025. See the trades.

Which famous investors hold WST?

10 of the 50 well-known investors we track reported WST in their latest 13F filing, including Bill Gates, Steve Cohen, Israel Englander. The largest position is worth $165M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.